Stock Events

Stock Events

Avalo Therapeutics (AVTX) Q1 2025 Earnings

20MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-141

-94.06

-47.11

-0.17

Details

Expected EPS

-0.168333

Actual EPS

-2.3

Surprise EPS

-2.13

Surprise Percent

+1,266.34%

Description

Avalo Therapeutics (AVTX) has reported earnings of -2.3 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.